UNI - Unilife Medical Solutions

[pacestick]

The consolidation with change to nasdaq in itself does not alter the total value of a shareholders holdings but it does expose their shares to a larger market '
The conversion maths seem to be 12 current shares become one USA share which becomes one CDI traded on the ASX each CDI is worth two shares and will be converted to us shares at anytime at the owners request

 

[pacestick]

UNI opened at 0.74 and closed at 0.80. With the make up of trades changing beginning late friday . There is now a an increased amount of large single trades indicating perhaps cashed up investors or even funds .

 

[LeeTV]

Unilife to Present at the Rodman and Renshaw Global Investment Conference
Sep 08, 2009 08:45 ET
http://www.marketwire.com/press-release/Unilife-Medical-Solutions-ASX-UNI-1040961.html

LEWISBERRY, PA--(Marketwire - September 8, 2009) - Unilife Medical Solutions Limited (ASX: UNI) (PINKSHEETS: UNIFF) today announced that it is scheduled to present at the 2009 Rodman & Renshaw Annual Global Investment Conference to be held in New York City between September 9-11, 2009.

The Rodman and Renshaw Healthcare Conference is an annual event attended by invited institutional investors, sophisticated investors and private equity firms specializing in the biotechnology and life sciences sector. The Unilife presentation, to be given by CEO Alan Shortall, marks the first time the Company will present at a major U.S. investment conference.

Unilife recently announced its intention to undertake a proposed redomiciliation of the Company from Australia to the U.S., and a proposed listing on NASDAQ.

The date, time and location of the Unilife presentation at the Conference are as follows:


Date: Thursday, September 10, 2009

Time: 4.30pm (U.S. Eastern Time)

Venue: Henry Salon (5th Floor), New York Palace Hotel, New York City
Unilife will place a copy of the presentation onto its website at www.unilife.com on Thursday, September 10 (U.S. Eastern Time).

Conference attendees seeking to schedule a one-on-one meeting with Unilife management between September 9 and 11, 2009 are encouraged to contact Stuart Fine via phone (+ 1 908 469 1788) or email stuart@carpedminc.com.

About Unilife

Unilife Medical Solutions Ltd. is an ISO 13485 certified company that designs, develops and supplies innovative safety medical devices. Listed on the Australian Securities Exchange (ASX: UNI) since 2002, Unilife has FDA-registered manufacturing facilities in the U.S. State of Pennsylvania and a proprietary portfolio of clinical and prefilled safety syringes designed for use within healthcare and pharmaceutical markets.

 

[LeeTV]

Nice close today. Someone stepped up to the plate and bought 135k worth on the close @ 87c. With the UNI presentation at the Rodman & Renshaw Annual Global Investment Conference tonight tomorrow will be an interesting day that's for certain.

 

[LeeTV]

Unilife Medical Solutions (UNI)
Written by DL
Thursday, 10 September 2009 04:01
Unilife Medical Solutions (UNI) Current price 84c

http://stocks2boom.com/joomla/index...utions-uni&catid=10:private-investor&Itemid=4

The writer has never actually made any money from investing in Biotech stocks. Held Arana when they were taken over at a 40% premium at $1.35 but as he’d bought at close to $2 couldn’t claim that as a win. Held a few employee options in another Biotech but left the company prior to them vesting, in any event a strike price of 90c and a current share price of 30c doesn’t make him feel any great sense of loss.

This time might well be different. UNI has been one of the star small cap performers in recent months. The writer an amateur chartist liked the chart at 33c and bought in at that point. On that day the company announced a partnership with Sanofi-Aventis an since then the share price has rocketed faster than the MD Alan Shortall’s conviction for speeding at 231 km an hour in 2005. http://www.smh.com.au/news/business...shortall-jailed/2005/06/23/1119321850987.html

There are a lot of listed companies trying to bring a safety syringe to market but it looks like Unilife will be the first with a truly safe compact syringe. The company has now established its production in the USA and over the next few months Sanofi-Aventis are to advise for which of their products they will use the syringe. UNI will be free to market the syringe to other companies for other applications and a royalty will be paid to Sanofi-Avenis.

A research report was recently produced by US brokers Griffin Securities and is available on UNI’s website. Whilst these reports always need to be viewed with a degree of skepticism given that these are often part of a larger deal it does give a good run down on the company and its prospects. The company is planning to list on the NASDAQ so that may add further interest to the company (expect Griffin Securities to be the arranging broker).

Expect a series of announcements from the company over coming months.

 

[LeeTV]

Rodman and Renshaw Presentation
10 September 2009
Unilife Medical Solutions Limited (UNI: ASX) CEO Alan Shortall presented at the 2009 Rodman and Renshaw Healthcare Conference in New York City.

A copy of the presentation has been placed below.

http://www.unilife.com//index.php?option=com_docman&task=doc_download&gid=60

 

[pacestick]

Rodman and Renshaw Presentation
10 September 2009
Unilife Medical Solutions Limited (UNI: ASX) CEO Alan Shortall presented at the 2009 Rodman and Renshaw Healthcare Conference in New York City.

The presentation may be the reason UNI jumped 0.10cents or 11.49% in trading today the number of shares traded was about 1.4 million. With shares being offered for sale being outnumbered at times ten to one by those being sought
pacestick is a UNI holder very happy

 

[pacestick]

If you had bought UNI early in the year at 0.17cents you would be feeling pretty good with the close at $1.14 today. However the share still has a long way to go to get to the hieights it had seven years ago. The forthcoming consolidation listing on the nasdaq commercialisation of the 1 ml syringe next quarter and on going commercialisation of the rtf syringe look like they could just do that with Uni looking at 20% of the RTF market by 2016 when that market isestimated to be 3 billion dollars and UNI having cogs at about 50%, The Griffen report seeing UNI as a buy over he next twelve months at up $3.60may in fact be some what conservative
In the meantime my uni shares go up now sitting at 225% gross profit making me a very happy little investor

 

[LeeTV]

Not much to add to that pacestick except, go you good thing! I got in at 34.5c so am more than happy with this little cracker. imo it's early days and there is plenty of upside to come.

 

[pacestick]

CROSS POSTED
UNI is receiving more coverage in the USA this may have contributed to yesterdays rise and could flow on into todays .Even without that as the time ticks away towards the end of the year and with the significant announcements expected re
1. Sanofi Aventis and how many more RTF syringes they will take
2. The announcement of who the other companies are looking at the UNI RTF syringe
3. The announcement of who the first customer is for the 1ml syringe and possibly recieving payment for the first shipment
4. Further details on the NASDAQ listing
The SP should therefore show some significant gain over the next quarter

 

[LeeTV]

All the boxes are ticked and it's blue sky ahead imo. This is a long termer for me so roll on the dividends :


Unilife Medical Solutions has $12.8m turnaround profit
28 Sep 2009
Source: News Bites
http://www.businessspectator.com.au...28m-turnaround-prof-WB5YP?OpenDocument&src=is

Unilife Medical Solutions Ltd on August 31 reported a $12.8 million net profit in the year to June 30, 2009 compared with a previous $8.6 million loss, on operating revenue up from $4.2 million to $40.4 million.

EPS was 6.2c.

There was no dividend.

Cash was up 50.3% to $4.5 million.

 

[LeeTV]

Breaking out nicely on good volumes.
Closed after hours on new 52 week high of $1.38
Thanks to snork69 for the chart

 

[pacestick]

yes leetv we are on target for above $2.00 BEFORE nasdaq listing.
at the rate it went today well before . I am enjoying this share which is only about 10% of where it will be in four months

 

[skyQuake]

Theres a rumour going around of a capital raising @ $1.25 on the cards. That might stall the momentum a bit

 

[skyQuake]

Theres a rumour going around of a capital raising @ $1.25 on the cards. That might stall the momentum a bit

Make that 85c
100characterpostfiller100characterpostfiller100characterpostfiller100characterpostfiller100characterpostfiller

 

[pacestick]

It may be relayed to the recent speil at investment confrence in the USA i.e. it may be being issued to an american who does not wish to wait for nasdaq

 

[LeeTV]

Make that 85c
100characterpostfiller100characterpostfiller100characterpostfiller100characterpostfiller100characterpostfiller

Good call skyQuake.

from the AFR...

"....specialised syringe manufactuer (including retractable and pre-filled syringes) Unilife Medical Solutions is rattling the tin for $50 million at an issue price of 85c a share in a share purchase plan and private placements to US and Australian investors. The deal is being done with the help of Yellow Brick Road, RBS Morgans and others and the raising follows a deal between Unilife and sanofi-aventis in July."

 

[JBR]

So is this a good thing for shareholders come monday morning when they re-open or will it bring its advancing share price to a sudden holt?

 

[pacestick]

Thats a very good question as the amount of shares is expected to increase by about 20% I expect the sp to tempoarily fall back . However to counter that I also expect the company to bring forward the positive announcements that are expected over the next two months . It should also be noted that with american and australian investors expected to be added to existing shareholders as per the AFR report on FridayIf these are important enough investors or funds others will follow pushing the SP up I am still confident of a SP about $2.00 by christmas It should also be noted that this is probably the fundraising predicted in the Griffin report for early next year

 

[LeeTV]

The dilution will be more like 26%, if the 85c figure reported by AFR is indeed correct as it's not set in stone as yet. Personally I think the sp will hold up well pre and post cap raising for a few reasons:

1) Unilife is getting noticed by more and more investors and for good reason. It's going places and the sp is going with it.

2) Long term holders will want maximum amount of any spp so over subsciption is a certainity.

3) Investors who are not already holding and were thinking of holding would want to get their foot in the door prior to the record date to ensure they get a piece of the spp.

4) The money from this spp is going toward increasing productivity rather than paying off debt.

5) Some solid blue chip institutional investors will help not hinder the company.